Fasting Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Delayed-Release Tablets 20 mg
Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan's rabeprazole
sodium delayed-release 20 mg tablets to Eisai's Aciphex® delayed-release 20 mg tablets
following a single, oral 20 mg (1 x 20 mg) dose administration under fasting conditions.